PWC News
Saturday, January 31, 2026
No Result
View All Result
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis
No Result
View All Result
PWC News
No Result
View All Result

Walgreens Boots Alliance’s Q4 results likely to reflect market challenges | AlphaStreet

Home Markets
Share on FacebookShare on Twitter


Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been struggling to take care of gross sales momentum and profitability for fairly a while resulting from a difficult working atmosphere. The primary headwinds to the enterprise are inflation-induced pressure on shopper spending and unfavorable market dynamics. Contemplating these elements, market watchers have issued not-so-optimistic estimates for the August quarter.

The market’s disappointment over Walgreens’ incapacity to remain resilient is seen within the efficiency of its inventory. WBA is without doubt one of the worst-performing shares that continuously underperformed the business and the broad market in latest instances. Final month, the shares slipped into the single-digit territory for the primary time in additional than twenty years. The worth has plunged round 67% to this point this 12 months.

The Deerfield-headquartered retail pharma large is about to publish its fourth-quarter report on Tuesday, October 15, at 7:00 am ET. The consensus earnings estimate for the ultimate three months of fiscal 2024 is $0.36 per share, which is sharply decrease than the $0.67 per share the corporate earned within the prior-year quarter. Gross sales are anticipated to extend modestly to $35.75 billion within the fourth quarter from $35.42 billion a 12 months earlier.

Slowdown

With household budgets coming underneath strain from the financial slowdown, Walgreens’ clients have turn into more and more price-conscious. The state of affairs has compelled the corporate to introduce promotional gives and reductions, which in flip put strain on near-term profitability. In the meantime, the corporate has initiated measures to make its enterprise mannequin sustainable, akin to renegotiating incentives with companions and partnering straight with pharma corporations to reap the benefits of its distinctive place out there.

Walgreens and its friends like CVS Well being have been going through stiff competitors from Amazon ever for the reason that latter entered the pharmacy retail area with the acquisition of PillPack about six years in the past. Whereas persevering with its efforts to spice up retailer visitors, Walgreens has revealed plans to shut practically a fourth of its shops, with a concentrate on unprofitable areas, because the shift to on-line prescriptions continues.

Within the three months ended Might 31, 2024, Walgreens’ gross sales grew throughout all three working segments, driving up the entire to $36.4 billion. Comparable pharmacy gross sales rose 5.7% year-over-year, whereas comparable retail gross sales dropped 2.3%. Excluding particular objects, third-quarter earnings decreased to $0.63 per share from $1.00 per share a 12 months earlier, primarily reflecting decrease sale-leaseback positive aspects and softness in retail and pharmacy efficiency.

Outlook

In the meantime, reported revenue greater than doubled to $344 million or $0.40 per share throughout the three months, aided by a lower in SG&A bills. Earnings missed Road View whereas revenues nearly matched estimates, after beating within the trailing two quarters. In an indication that the pressure on profitability has prolonged into the second half, the Walgreens management forecasts adjusted earnings per share within the $2.80-2.95 vary for fiscal 2024, which is under the prior-year quantity.

“As we sit up for the rest of the 12 months, we’re working underneath the next assumptions. We count on the working atmosphere to stay difficult. We don’t count on an enchancment within the U.S. retail atmosphere. And eventually, we count on script quantity development to stay muted and anticipate continued pressures on pharmacy margins. In gentle of those elements, we’re decreasing our outlook. We now count on to ship adjusted earnings per share of $2.80 to $2.95 for the fiscal 12 months 2024,” stated Walgreens’ CEO Tim Wentworth throughout the Q3 earnings name.

Walgreens’ inventory has been languishing under its 12-month common for round 5 months. After dropping a dismal 54% up to now six months, the shares traded barely larger on Monday afternoon.  



Source link

Tags: AlliancesAlphaStreetBootsChallengesmarketreflectResultsWalgreens
Previous Post

Apple-owned Beats enters Indian market with launch of three products – Details

Next Post

Tim Walz goes on Fox News and attacks Trump’s economic agenda

Related Posts

Seacoast Banking Reports Q4 and Full-Year 2025 Results, Boosted by Balance Sheet Expansion | AlphaStreet
Markets

Seacoast Banking Reports Q4 and Full-Year 2025 Results, Boosted by Balance Sheet Expansion | AlphaStreet

January 31, 2026
Trump nominates Kevin Warsh for Federal Reserve chair to succeed Jerome Powell
Markets

Trump nominates Kevin Warsh for Federal Reserve chair to succeed Jerome Powell

January 30, 2026
Software stocks enter bear market on AI disruption fear with ServiceNow plunging 10%
Markets

Software stocks enter bear market on AI disruption fear with ServiceNow plunging 10%

January 31, 2026
A Long-Read Duopoly – PacBio or Oxford Nanopore? – Nanalyze
Markets

A Long-Read Duopoly – PacBio or Oxford Nanopore? – Nanalyze

January 30, 2026
Chart of the Week: Two Superpowers, Two Energy Futures
Markets

Chart of the Week: Two Superpowers, Two Energy Futures

January 30, 2026
Corning Incorporated (GLW) Q4 2025 Earnings Call Transcript | AlphaStreet
Markets

Corning Incorporated (GLW) Q4 2025 Earnings Call Transcript | AlphaStreet

January 29, 2026
Next Post
Tim Walz goes on Fox News and attacks Trump’s economic agenda

Tim Walz goes on Fox News and attacks Trump’s economic agenda

2024 NASDAQ 100 Stocks List Spreadsheet | Daily Data Updates

2024 NASDAQ 100 Stocks List Spreadsheet | Daily Data Updates

OSC appoints former Ontario auditor general to lead enforcement effort

OSC appoints former Ontario auditor general to lead enforcement effort

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

The Next Bottleneck in the AI Boom Isn’t Chips
Markets

The Next Bottleneck in the AI Boom Isn’t Chips

by PWC
January 28, 2026
0

Two years in the past, Elon Musk predicted that electrical energy shortages could be the subsequent huge drawback going through...

How Healthy Are Greenland’s Glaciers? – 2GreenEnergy.com

How Healthy Are Greenland’s Glaciers? – 2GreenEnergy.com

January 29, 2026
Meltdown: GOP pollster predicts Trump pivot as job ‘not fun’ when ‘public doesn’t applaud’

Meltdown: GOP pollster predicts Trump pivot as job ‘not fun’ when ‘public doesn’t applaud’

January 27, 2026
BMI Launches Country-Level ESG and Climate Risk Data Solution – ESG Today

BMI Launches Country-Level ESG and Climate Risk Data Solution – ESG Today

January 29, 2026
Investor signs MoU to buy BioProtect for 0m

Investor signs MoU to buy BioProtect for $200m

January 28, 2026
21Shares sees XRP trading at .45 in 2026 base case

21Shares sees XRP trading at $2.45 in 2026 base case

January 28, 2026
PWC News

Copyright © 2024 PWC.

Your Trusted Source for ESG, Corporate, and Financial Insights

  • About Us
  • Advertise with Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact Us

Follow Us

No Result
View All Result
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis

Copyright © 2024 PWC.